Skip to content
healthcare.dev

neostigmine methylsulfate

NDC 71288-500, neostigmine methylsulfate, injection, from Meitheal Pharmaceuticals Inc..

Product NDC
71288-500
Status
Listed
Labeler
Meitheal Pharmaceuticals Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212804
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71288-500 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEOSTIGMINE METHYLSULFATE.51 mg/mL

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
71288-500-117128805001110 VIAL, MULTI-DOSE in 1 CARTON (71288-500-11) / 10 mL in 1 VIAL, MULTI-DOSE (71288-500-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5a01a429-a346-4253-8994-b58d34b57974

Use it

Look up 71288-500 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71288-500 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71288-500. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.